Skip to content
My WebMD Sign In, Sign Up

Breast Cancer Health Center

Medical Reference Related to Breast Cancer

  1. Breast Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Breast Cancer Screening Modalities—Beyond Mammography

    Clinical Breast ExaminationNo randomized trials of clinical breast examination (CBE) as a sole screening modality have yet been reported. The Canadian National Breast Screening Study (NBSS) compared high-quality CBE plus mammography to CBE alone in women aged 50 to 59 years (refer to the Clinical Breast Examination section in the Overview section of this summary for more information). CBE, lasting 5 to 10 minutes per breast, was conducted by trained health professionals, with periodic evaluations of performance quality. The frequency of cancer diagnosis, stage, interval cancers, and breast cancer mortality were similar in the two groups and compared favorably with other trials of mammography alone, perhaps because of the careful training and supervision of the health professionals performing CBE.[1] Breast cancer mortality with follow-up 11 to 16 years after entry (mean = 13 years) was similar in the two screening arms (mortality rate ratio, 1.02 [95% confidence interval

  2. Breast Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Characteristics of Cancers Detected by Screening Mammography

    Several studies have shown that the method of cancer detection is a powerful predictor of patient outcome,[1] which is useful for prognostication and treatment decisions. All of the studies accounted for stage, nodal status, and tumor size.A 10-year follow-up study of 1,983 Finnish women with invasive breast cancer demonstrated that the method of cancer detection is an independent prognostic variable. When controlled for age, nodal status, and tumor size, screen-detected cancers had a lower risk of relapse and better overall survival. For women whose cancers were detected outside screening, the hazard ratio (HR) for death was 1.90 (95% confidence interval [CI], 1.15–3.11), even though they were more likely to receive adjuvant systemic therapy.[2]Similarly, an examination of the breast cancers found in three randomized screening trials (Health Insurance Plan, National Breast Screening Study [NBSS]-1, and NBSS-2) accounted for stage, nodal status, and tumor size and determined

  3. Breast Cancer Screening (PDQ®): Screening - Patient Information [NCI] - nci_ncicdr0000257995-nci-header

    This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Breast Cancer Screening

  4. Genetics of Breast and Ovarian Cancer (PDQ®): Genetics - Health Professional Information [NCI] - About This PDQ Summary

    PURPOSE OF THIS SUMMARY This PDQ cancer information summary for health professionals provides comprehensive,peer-reviewed,evidence-based information about the genetics of breast and ovarian cancer. It is intended as a resource to inform and assist clinicians who care for cancer patients. It does not provide formal guidelines or recommendations for making health care decisions. REVIEWERS AND ...

  5. Breast Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - nci_ncicdr0000062955-nci-header

    This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Breast Cancer Treatment

  6. Breast Cancer Prevention (PDQ®): Prevention - Health Professional Information [NCI] - Overview

    Factors Associated with Increased Risk of Breast Cancer

  7. Breast Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - Get More Information From NCI

    Sources of further information about Breast Cancer Treatment.

  8. Breast Cancer Prevention (PDQ®): Prevention - Patient Information [NCI] - Get More Information From NCI

    Sources of further information about breast cancer prevention.

  9. Breast Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Cellular Classification of Breast Cancer

    The following is a list of breast cancer histologic classifications.[

  10. Breast Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Triple-Negative Breast Cancer

    Triple-negative breast cancer (TNBC) is defined as the absence of staining for estrogen receptor,progesterone receptor,and HER2/neu. TNBC is insensitive to some of the most effective therapies available for breast cancer treatment including HER2 -directed therapy such as trastuzumab and endocrine therapies such as tamoxifen or the aromatase inhibitors. Combination cytotoxic chemotherapy ...

Displaying 111 - 120 of 285 Articles << Prev Page 8 9 10 11 12 13 14 15 16 17 Next >>

Today on WebMD

Breast Cancer Overview
From self-exams and biopsies to reconstruction, we’ve got you covered.
Dealing with breast cancer
Get answers to your questions.
 
woman having mammogram
Experts don’t agree on all fronts, but you can be your own advocate.
woman undergoing breast cancer test
Many women worry. But the truth? Most abnormalities aren’t breast cancer.
 
Breast Cancer Treatments Improving
VIDEO
Resolved To Quit Smoking
SLIDESHOW
 
Woman getting mammogram
Article
Screening Tests for Women
SLIDESHOW
 
ovarian cancer overview slideshow
SLIDESHOW
serious woman
Article
 
what is your cancer risk
HEALTH CHECK
10 Ways to Revitalize Slideshow
SLIDESHOW